Luciano Adorini mainly focuses on Immunology, Cell biology, T cell, Cytokine and CD40. As a part of the same scientific study, Luciano Adorini usually deals with the Immunology, concentrating on Interleukin 12 and frequently concerns with Immune regulation. His work carried out in the field of Cell biology brings together such families of science as Cellular differentiation, Cell growth, Secretion, Calcitriol receptor and Neuroinflammation.
His T cell study combines topics from a wide range of disciplines, such as Cytotoxic T cell and Antigen. Luciano Adorini interconnects Pathogenesis, Gastroenterology, Prostatitis, Microglia and Immune system in the investigation of issues within Cytokine. His studies examine the connections between CD40 and genetics, as well as such issues in CD86, with regards to CD80.
His main research concerns Immunology, Molecular biology, Internal medicine, T cell and Endocrinology. His Immunology research integrates issues from Interleukin 12 and In vivo. His Molecular biology research is multidisciplinary, incorporating perspectives in In vitro, Lysozyme and Epitope, Antibody, Antigen.
Luciano Adorini has researched Internal medicine in several fields, including Diabetes mellitus, Metabolic syndrome and RHOA. His biological study spans a wide range of topics, including Cytotoxic T cell and Cell biology. His research investigates the connection with Cell biology and areas like CD40 which intersect with concerns in CD86.
The scientist’s investigation covers issues in Internal medicine, Endocrinology, G protein-coupled bile acid receptor, Agonist and Metabolic syndrome. His research integrates issues of Farnesoid X receptor and RHOA in his study of Internal medicine. His studies deal with areas such as Inflammation and Lower urinary tract symptoms, Prostate as well as Endocrinology.
In his study, which falls under the umbrella issue of Agonist, Bioinformatics, Computational biology, Signal transduction and Derivative is strongly linked to Bile acid. As part of one scientific family, Luciano Adorini deals mainly with the area of Cancer research, narrowing it down to issues related to the Pancreatic lesion, and often Immunology. His Immunology research includes themes of Peripheral blood mononuclear cell and Replication.
His primary areas of study are Internal medicine, Endocrinology, Inflammation, Chemokine and Stromal cell. Luciano Adorini combines subjects such as Farnesoid X receptor and RHOA with his study of Internal medicine. His Inflammation research is multidisciplinary, incorporating elements of Prostatitis, Lower urinary tract symptoms, Androgen, Testosterone and Fibrosis.
To a larger extent, Luciano Adorini studies Immunology with the aim of understanding Chemokine. His Interleukin 8 research includes elements of Cancer research, Paracrine signalling, CXCL10, Proinflammatory cytokine and Major histocompatibility complex. The study incorporates disciplines such as Hyperplasia, Interleukin 12, Dihydrotestosterone and Rho-associated protein kinase in addition to Cytokine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune Responses
Maurice K. Gately;Louis M. Renzetti;Jeanne Magram;Alvin S. Stern.
Annual Review of Immunology (1998)
1α,25-Dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell Activation
Giuseppe Penna;Luciano Adorini.
Journal of Immunology (2000)
Maturation Stages of Mouse Dendritic Cells in Growth Factor–dependent Long-Term Cultures
Claudia Winzler;Patrizia Rovere;Maria Rescigno;Francesca Granucci.
Journal of Experimental Medicine (1997)
Regulatory T Cells Induced by 1α,25-Dihydroxyvitamin D3 and Mycophenolate Mofetil Treatment Mediate Transplantation Tolerance
Silvia Gregori;Mara Casorati;Susana Amuchastegui;Simona Smiroldo.
Journal of Immunology (2001)
The coming of age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents
Chantal Mathieu;Luciano Adorini.
Trends in Molecular Medicine (2002)
A 1α,25-Dihydroxyvitamin D3 Analog Enhances Regulatory T-Cells and Arrests Autoimmune Diabetes in NOD Mice
Silvia Gregori;Nadia Giarratana;Simona Smiroldo;Milan Uskokovic.
Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice.
S Trembleau;G Penna;E Bosi;A Mortara.
Journal of Experimental Medicine (1995)
Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: Implications for myocardium regeneration
G. Condorelli;U. Borello;L. De Angelis;M. Latronico.
Proceedings of the National Academy of Sciences of the United States of America (2001)
Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes.
Francesca Aloisi;Francesco Ria;Luciano Adorini.
Immunology Today (2000)
Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3.
Giuseppe Penna;Andrea Roncari;Susana Amuchastegui;Kenn C. Daniel.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: